Log in to save to my catalogue

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among...

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7982504

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

About this item

Full title

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

Publisher

Switzerland: International AIDS Society

Journal title

Journal of the International AIDS Society, 2021-03, Vol.24 (3), p.e25690-n/a

Language

English

Formats

Publication information

Publisher

Switzerland: International AIDS Society

More information

Scope and Contents

Contents

Background
Expanding statin use may help to alleviate the excess burden of atherosclerotic cardiovascular disease in people living with HIV (PLHIV). Pravastatin and pitavastatin are preferred agents due to their lack of substantial interaction with antiretroviral therapy. We aimed to evaluate the cost‐effectiveness of pravastatin and pitavastati...

Alternative Titles

Full title

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7982504

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7982504

Other Identifiers

ISSN

1758-2652

E-ISSN

1758-2652

DOI

10.1002/jia2.25690

How to access this item